First-in-human study of DM002, an anti-MUC1/HER3 bispecific antibody-drug conjugate, in patients with advanced solid tumors.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Xian Jun Yu, Jian Zhang, Udit Nindra, Joe Wei, Siqing Fu, Ganessan Kichenadasse, Guiling Li, Zhisong He, Jundong Li, Yuanming Shen, Xiaohua Wu
Institutions: Fudan University Shanghai Cancer Center, The University of Texas MD Anderson Cancer Center, Flinders Medical Centre, Wuhan Union Hospital, Huazhong University of Science and Technology, Peking University, Peking University First Hospital, Sun Yat-sen University Cancer Center, Women's Hospital, School of Medicine, Zhejiang University
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162485848
Cites:
Cited by:
Related to: